Brief: Gubra Narrows 2026 Guidance For CRO Revenue Growth To 2-6%
Today 06:06
BRIEF-Gubra Narrows 2026 Guidance For CRO Revenue Growth To 2-6% Nov 6 (Reuters) - Gubra A/S GUBRA.CO:
FULL-YEAR 2026 GUIDANCE FOR CRO REVENUE GROWTH HAS BEEN NARROWED TO 2-6% (PREVIOUSLY 0-10%)
2026 OUTLOOK: EBIT MARGIN GUIDANCE HAS BEEN NARROWED TO 10-13% (PREVIOUSLY 10-15%)
2026 OUTLOOK: BIOTECH FULL-YEAR COST GUIDANCE HAS BEEN REDUCED SLIGHTLY TO DKK 315-335 MILLION (PREVIOUSLY DKK 330-360 MILLION)
Q3 EBIT MARGIN REACHING 25%
Q3 REVENUE-EXTERNAL DKK 447.7 MILLION
Source text: ID:nMFN3RJdV4
Further company coverage: GUBRA.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))